ALSHIFA PHARMA SCIENTIFIC DRUG — Saxagliptin Importer Profile
Pharmaceutical Importer · #3 buyer for Saxagliptin · $259.3K import value · 10 shipments · IRAQ · DGFT Verified
ALSHIFA PHARMA SCIENTIFIC DRUG is the #3 importer of Saxagliptin from India with $259.3K in import value and 10 verified shipments. ALSHIFA PHARMA SCIENTIFIC DRUG holds a 6.5% market share in Saxagliptin imports based in IRAQ. The company sources from 1 verified supplier across 1 formulations shipped to 1 country.
ALSHIFA PHARMA SCIENTIFIC DRUG — Saxagliptin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Saxagliptin to ALSHIFA PHARMA SCIENTIFIC DRUG?
Verified from 10 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SAM LIFESTYLE | $259.3K | 10 | 100.0% |
ALSHIFA PHARMA SCIENTIFIC DRUG sources Saxagliptin from 1 verified Indian supplier based on 10 customs records. The primary supplier is SAM LIFESTYLE accounting for 100.0% of imports.
How Does ALSHIFA PHARMA SCIENTIFIC DRUG Compare to Nearest Saxagliptin Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $850.0K | 17 | $50.0K |
| 2 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $850.0K | 17 | $50.0K |
| 3 | ALSHIFA PHARMA SCIENTIFIC DRUG ★ | IRAQ | $259.3K | 10 | $25.9K |
| 4 | GLENMARK PHARMACEUTICALS INC | UNITED STATES | $45.2K | 2 | $22.6K |
| 5 | MYLAN PHARMACEUTICALS INC,. | UNITED STATES | $25.7K | 3 | $8.6K |
ALSHIFA PHARMA SCIENTIFIC DRUG ranks #3 among 41 Saxagliptin importers from India. Average shipment value of $25.9K compared to the market average of $50.8K. The closest competitors by value are MYLAN PHARMACEUTICALS INC, and MYLAN PHARMACEUTICALS INC.
Where Does ALSHIFA PHARMA SCIENTIFIC DRUG Import Saxagliptin To?
Destination countries from 10 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $259.3K | 10 | 100.0% |
ALSHIFA PHARMA SCIENTIFIC DRUG imports Saxagliptin to 1 country. The primary destination is IRAQ receiving 100.0% of shipments worth $259.3K.
What Saxagliptin Formulations Does ALSHIFA PHARMA SCIENTIFIC DRUG Import?
| Formulation | Value | Shipments |
|---|---|---|
| SAXAGLIPTIN 5 MG PLUS METFORMIN 1000 MGEXTENDED RELEASE TABLET OTHER DETAIL ASPER INVOICE | $259.3K | 10 |
ALSHIFA PHARMA SCIENTIFIC DRUG imports 1 distinct Saxagliptin formulations from India. The top formulation is SAXAGLIPTIN 5 MG PLUS METFORMIN 1000 MGEXTENDED RELEASE TABL with 10 shipments worth $259.3K.
Who Are the Top Buyers of Saxagliptin from India and How Much Does ALSHIFA PHARMA SCIENTIFIC DRUG Import?
India exported $2.1M worth of Saxagliptin through 258 shipments from 30 suppliers to 16 countries, serving 41 buyers globally. ALSHIFA PHARMA SCIENTIFIC DRUG imports $259.3K of this total, accounting for 6.5% of India's Saxagliptin exports with 10 shipments from IRAQ. This is verified from 10 customs shipment records covering 1 distinct formulations.
What Is the Average Order Value for ALSHIFA PHARMA SCIENTIFIC DRUG's Saxagliptin Imports?
ALSHIFA PHARMA SCIENTIFIC DRUG's average Saxagliptin order value is $25.9K per consignment, based on 10 shipments totaling $259.3K. ALSHIFA PHARMA SCIENTIFIC DRUG is based in IRAQ and ranks #3 among all Saxagliptin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Saxagliptin to ALSHIFA PHARMA SCIENTIFIC DRUG?
ALSHIFA PHARMA SCIENTIFIC DRUG sources Saxagliptin from 1 verified Indian supplier: SAM LIFESTYLE ($259.3K, 100.0%). This is based on 10 customs records.
How Does ALSHIFA PHARMA SCIENTIFIC DRUG Compare to Other Saxagliptin Importers?
ALSHIFA PHARMA SCIENTIFIC DRUG ranks #3 among 41 Saxagliptin importers from India with a 6.5% market share. The top 3 importers are MYLAN PHARMACEUTICALS INC, ($850.0K), MYLAN PHARMACEUTICALS INC ($850.0K), ALSHIFA PHARMA SCIENTIFIC DRUG ($259.3K). ALSHIFA PHARMA SCIENTIFIC DRUG processed 10 shipments from IRAQ.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Saxagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Saxagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ALSHIFA PHARMA SCIENTIFIC DRUG matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ALSHIFA PHARMA SCIENTIFIC DRUG's capped import value divided by total capped export value for Saxagliptin across all Indian exporters.
- 5.Verified Records: This page is backed by 10 individual customs records matching ALSHIFA PHARMA SCIENTIFIC DRUG importing Saxagliptin, covering 1 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 16+ countries, 41+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Saxagliptin Import Data for ALSHIFA PHARMA SCIENTIFIC DRUG
Access order-level details, pricing data, supplier connections, and competitive analysis for ALSHIFA PHARMA SCIENTIFIC DRUG's Saxagliptin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ALSHIFA PHARMA SCIENTIFIC DRUG
Company Profile
Multiple products · $0 total trade · Multiple categories
ALSHIFA PHARMA SCIENTIFIC DRUG × Saxagliptin
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ALSHIFA PHARMA SCIENTIFIC DRUG.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Saxagliptin. For current order-level data, contact TransData Nexus.